A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,722

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Irritable Bowel Syndrome With Constipation (IBS-C)
Interventions
DRUG

Placebo

matching Placebo Capsules, Oral, once daily

DRUG

Linaclotide

Linaclotide 290 ug Capsules, Oral, once daily

Trial Locations (82)

Unknown

Research Site, Huntsville

Research Site, North Little Rock

Research Site, Phoenix

Research Site, Artesia

Research Site, Chula Vista

Research Site, Encino

Research Site, North Hollywood

Research Site, Orange

Research Site, Riverside

Research Site, San Diego

Research Site, Boynton Beach

Research Site, Brandon

Research Site, Brooksville

Research Site, Doral

Research Site, Gainesville

Research Site, Hialeah

Research Site, Kissimmee

Research Site, Lauderdale Lakes

Research Site, Miami

Research Site, Miami Lakes

Research Site, Addison

Research Site, Evansville

Research Site, Crowley

Research Site, Monroe

Research Site, Shreveport

Research Site, Boston

Research Site, Chesterfield

Research Site, Wyoming

Research Site, St Louis

Research Site, Billings

Research Site, Las Vegas

Research Site, Brooklyn

Research Site, Great Neck

Research Site, New York

Research Site, Raleigh

Research Site, Salisbury

Research Site, Winston-Salem

Research Site, Cincinnati

Research Site, Dayton

Research Site, Franklin

Research Site, Mentor

Research Site, Greer

Research Site, Chattanooga

Research Site, Kingsport

Research Site, Knoxville

Research Site, Smyrna

Research Site, Houston

Research Site, San Antonio

Research Site, Webster

Research Site, Ogden

Research Site, Lynchburg

Research Site, Morgantown

Research Site, Adelaide

Research Site, Brisbane

Research Site, Five Dock

Research Site, Malvern

Research Site, Maroubra

Research Site, Melbourne

Research Site, Parkville

Research Site, Vaughan

Research Site, Beijing

Research Site, Changsha

Research Site, Chengdu

Research Site, Chongqing

Research Site, Guangzhou

Research Site, Hangzhou

Research Site, Harerbin

Research Site, Hefei

Research Site, Jinan

Research Site, Nanchang

Research Site, Qingdao

Research Site, Shanghai

Research Site, Shenyang

Research Site, Shijiazhuang

Research Site, Wuhan

Research Site, Xi'an

Research Site, Xiamen

Research Site, Auckland

Research Site, Christchurch

Research Site, Dunedin

Research Site, Tauranga

Research Site, Wellington

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Ironwood Pharmaceuticals, Inc.

INDUSTRY

lead

AstraZeneca

INDUSTRY